Compounded GLP-1 injections recalled nationwide: 4 notes

Apothecary Pharma is recalling 22 vials of compounded tirzepatide injection nationwide over a lack of assurance of sterility, according to an Oct. 8 FDA notice. Here are four things to know: The post Compounded GLP-1 injections recalled nationwide: 4 notes appeared first on Becker's Hospital Review | Healthcare News & Analysis.

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.